Cargando…

Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling

Higher levels of hyaluronan (HA) and its receptors CD44 and RHAMM have been associated with poor prognosis and metastasis in NSCLC. In the current study, our goal was to define, using cellular and orthotopic lung tumor models, the role of HA-CD44/RHAMM signaling in lung carcinogenesis and to assess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Jung Min, Molla, Kalkidan, Anandharaj, Arunkumar, Cornax, Ingrid, O`Sullivan, M. Gerard, Kirtane, Ameya R., Panyam, Jayanth, Kassie, Fekadu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432308/ https://www.ncbi.nlm.nih.gov/pubmed/28460475 http://dx.doi.org/10.18632/oncotarget.15879

Ejemplares similares

Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors
por: Song, Jung Min, et al.
Publicado: (2016)

The Roles of Hyaluronan/RHAMM/CD44 and Their Respective Interactions along the Insidious Pathways of Fibrosarcoma Progression
por: Nikitovic, Dragana, et al.
Publicado: (2013)

Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer
por: Misra, Suniti, et al.
Publicado: (2015)

Hyaluronan and RHAMM in Wound Repair and the “Cancerization” of Stromal Tissues
por: Tolg, Cornelia, et al.
Publicado: (2014)

TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan
Publicado: (1993)

Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity
Publicado: (1994)

Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer
por: Khanna, Vidhi, et al.
Publicado: (2019)

Uncovering the dual role of RHAMM as an HA receptor and a regulator of CD44 expression in RHAMM-expressing mesenchymal progenitor cells
por: Veiseh, Mandana, et al.
Publicado: (2015)

Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression
Publicado: (1996)

The hyaluronan-mediated motility receptor RHAMM promotes growth, invasiveness and dissemination of colorectal cancer
por: Mele, Valentina, et al.
Publicado: (2017)

The Impact of the Receptor of Hyaluronan-Mediated Motility (RHAMM) on Human Urothelial Transitional Cell Cancer of the Bladder
por: Niedworok, Christian, et al.
Publicado: (2013)

The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan
Publicado: (1992)

Editorial: Interaction Between Hyaluronic Acid and Its Receptors (CD44, RHAMM) Regulates the Activity of Inflammation and Cancer
por: Naor, David
Publicado: (2016)

CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL)
por: Oldenburg, Darby, et al.
Publicado: (2016)

Atomistic fingerprint of hyaluronan–CD44 binding
por: Vuorio, Joni, et al.
Publicado: (2017)

Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Publicado: (1996)

Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy
por: Arora, Sumit, et al.
Publicado: (2014)

Antitumor effect of 4MU on glioblastoma cells is mediated by senescence induction and CD44, RHAMM and p-ERK modulation
por: Pibuel, Matías Arturo, et al.
Publicado: (2021)

Reformulating Tylocrebrine in Epidermal Growth Factor Receptor Targeted Polymeric Nanoparticles Improves Its Therapeutic Index
por: Kirtane, Ameya R., et al.
Publicado: (2015)

Monoclonal antibodies to CD44 and their influence on hyaluronan recognition
Publicado: (1995)

The Role of Hyaluronan and CD44 in the Pathogenesis of Lupus Nephritis
por: Yung, Susan, et al.
Publicado: (2012)

Interactions between CD44 and Hyaluronan in Leukocyte Trafficking
por: McDonald, Braedon, et al.
Publicado: (2015)

Rhamm(−/−) fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair
por: Tolg, Cornelia, et al.
Publicado: (2006)

Emodin regulates cell cycle of non-small lung cancer (NSCLC) cells through hyaluronan synthase 2 (HA2)-HA-CD44/receptor for hyaluronic acid-mediated motility (RHAMM) interaction-dependent signaling pathway
por: Li, Mingzhu, et al.
Publicado: (2021)

Changes in Hyaluronan Metabolism and RHAMM Receptor Expression Accompany Formation of Complicated Carotid Lesions and May be Pro-Angiogenic Mediators of Intimal Neovessel Growth
por: Krupinski, Jerzy, et al.
Publicado: (2008)

Hyaluronan (HA) Interacting Proteins RHAMM and Hyaluronidase Impact Prostate Cancer Cell Behavior and Invadopodia Formation in 3D HA-Based Hydrogels
por: Gurski, Lisa A., et al.
Publicado: (2012)

“RHAMM knockout” mice express a truncated RHAMM protein that promotes pancreatic cancer progression with dysfunctional p53
por: Chen, Xiang, et al.
Publicado: (2022)

Glycosylation of CD44 negatively regulates its recognition of hyaluronan
Publicado: (1995)

Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
por: Ween, Miranda P., et al.
Publicado: (2011)

Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics
por: Chaudhry, Gul-e-Saba, et al.
Publicado: (2021)

CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma
Publicado: (1996)

Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons
Publicado: (1995)

CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells
por: Zöller, Margot
Publicado: (2015)

The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer
por: Cirillo, Nicola
Publicado: (2023)

RHAMM deficiency disrupts folliculogenesis resulting in female hypofertility
por: Li, Huaibiao, et al.
Publicado: (2015)

Increased RHAMM expression relates to ovarian cancer progression
por: Buttermore, Stephanie T., et al.
Publicado: (2017)

RHAMM Is a Multifunctional Protein That Regulates Cancer Progression
por: Messam, Britney J., et al.
Publicado: (2021)

The role of RHAMM in cancer: Exposing novel therapeutic vulnerabilities
por: Hinneh, Josephine A., et al.
Publicado: (2022)

The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44
por: Zhao, Chunmei, et al.
Publicado: (2019)

Lipid Raft-Mediated Regulation of Hyaluronan–CD44 Interactions in Inflammation and Cancer
por: Murai, Toshiyuki
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p5gmd1pkkqipkga0gddc0r6ppm